|
产品描述
|
Certainly! It sounds like you're looking to enhance the product information for Factor XI, a biological product. Here's a structured approach to supplementing and improving the information across the specified categories:
Storage
- Temperature: Store Factor XI at -20°C to maintain stability and prevent degradation. Avoid repeated freeze-thaw cycles.
- Conditions: Keep the product in a dry environment, away from direct sunlight and moisture.
- Shelf Life: Under proper storage conditions, Factor XI remains stable for up to 12 months. Always refer to the specific expiry date on the packaging.
- Handling: Use aseptic techniques to prevent contamination. Upon thawing, store at 4°C and use within 24 hours.
Product Description
- Nature: Factor XI is a coagulation factor involved in the intrinsic pathway of blood coagulation.
- Source: It is typically derived from human plasma or produced recombinantly.
- Formulation: Available as a lyophilized powder or liquid concentrate, ensuring ease of reconstitution and application.
- Concentration: Specific concentrations vary; consult the product label for exact details.
Key Features
- Purity: High-purity formulation minimizes the risk of adverse reactions and enhances efficacy.
- Activity: Biologically active, with a specified activity level measured in international units (IU).
- Safety: Tested for viral inactivation and contamination, ensuring high safety standards.
- Compatibility: Can be integrated into various experimental setups, including in vitro assays and clinical research.
What's Included
- Factor XI Vial: The main product, provided in a sealed vial.
- Reconstitution Buffer: Included for easy preparation and use.
- User Manual: Detailed instructions on usage, storage, and handling.
- Certificate of Analysis: Document confirming product specifications and quality control measures.
Applications
- Research: Widely used in coagulation studies, thrombosis research, and the investigation of bleeding disorders.
- Clinical: Potential applications in treating Factor XI deficiency and managing hemophilia C.
- Diagnostics: Utilized in assays to evaluate coagulation pathways and screen for coagulation factor deficiencies.
- Biotechnology: Employed in the development of therapeutic interventions targeting coagulation pathways.
By enhancing the product information with these detailed aspects, users will have a comprehensive understanding of Factor XI, its handling, and its diverse applications in research and clinical settings.
|